Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,214,846
+$528,828 QoQ
Shares Held
385,999
+2.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $48,125,230 across 32 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
80,566 | $9,523,706 | |
| 2 | VTRS |
Viatris Inc
This page
|
385,999 | $5,214,846 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,648 | $5,128,091 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
224,015 | $4,148,757 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
121,502 | $2,907,542 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
20,245 | $2,667,076 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,216 | $2,626,945 | |
| 8 | HLN |
Haleon plc
|
247,741 | $2,479,887 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,214,846 | 385,999 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,686,018 | 376,387 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,849,456 | 388,834 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,842,222 | 318,278 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,555,688 | 293,420 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,481,505 | 279,639 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,163,179 | 272,453 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,785,006 | 261,995 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $3,507,148 | 293,731 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $773,262 | 71,400 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $727,421 | 73,775 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,089,554 | 409,775 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,378,533 | 455,149 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,352,750 | 480,930 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,124,847 | 484,137 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,101,570 | 487,256 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,537,484 | 508,960 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,963,945 | 514,704 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,741,545 | 497,531 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,565,826 | 529,449 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,653,548 | 547,856 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,075,568 | 377,565 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||